About the Division of Hematology/Oncology
The Division of Hematology/Oncology is an integral part of the University of Pittsburgh Cancer Institute (UPCI) and emphasizes clinical care, research, and teaching.
Watch our experts discuss UPCI and UPMC CancerCenter:
|Edward Chu, MD, Chief,
Division of Hematology/Oncology
|Mark Socinski, MD, Co-Director, UPMC Lung Cancer Center of Excellence, Director, Lung Cancer Disease Section|
Programs within the division include:
- Clinical hematology
- Hematological malignancies
- Hematopoietic stem cell transplantation
- Solid tumor oncology
The facilities of the division include:
- A well-respected bone marrow transplant unit.
- Fully staffed hematology/oncology outpatient clinics in UPCI for administration of cancer therapies and for clinical research and therapeutic trials.
- An outstanding inpatient unit at UPMC Shadyside where patients can receive standard and investigational cancer treatments.
In addition to the on-site patient care programs, the division maintains a network of oncologists and hematologists who assist in the conduct of its numerous clinical trials.
Central to this network are:
- Hematology/Oncology Associates, a 17-member group acquired by UPMC
- Oncology Hematology Associates, a 25-member group
These cadres of physicians articulate the hematology/oncology program of UPMC throughout western Pennsylvania.